Absorption Kinetics after Inhalation of Fluticasone Propionate via the Diskhaler®, Diskus® and Metered-Dose Inhaler in Healthy Volunteers Charles BrindleyChristine FalcozAlan Bye Original Research Article 18 October 2012 Pages: 1 - 8
Bioavailability of Orally Administered Micronised Fluticasone Propionate Christine FalcozRuth OliverPeter T. Daley-Yates Original Research Article 18 October 2012 Pages: 9 - 15
Systemic Exposure to Fluticasone Propionate Administered via Metered-Dose Inhaler Containing Chlorofluorocarbon or Hydrofluoroalkane Propellant Alison E. MackieJo E. McDowallPeter T. Daley-Yates Original Research Article 18 October 2012 Pages: 17 - 22
Pharmacokinetics of Fluticasone Propionate Inhaled via the Diskhaler® and Diskus® Powder Devices in Healthy Volunteers Alison E. MackieJo E. McDowallPeter T. Daley-Yates Original Research Article 18 October 2012 Pages: 23 - 30
Pharmacokinetics of Fluticasone Propionate Inhaled via the Diskhaler® and Diskus® Powder Devices in Patients with Mild-to-Moderate Asthma Christine FalcozJohn HortonPeter T. Daley-Yates Original Research Article 18 October 2012 Pages: 31 - 37
Comparison of the Systemic Availability of Fluticasone Propionate in Healthy Volunteers and Patients with Asthma Peter T. Daley-YatesJulien TournantRobert L. Kunka Original Research Article 18 October 2012 Pages: 39 - 45
The Relationship between Systemic Exposure to Fluticasone Propionate and Cortisol Reduction in Healthy Male Volunteers Alison E. MackieAlan Bye Original Research Article 18 October 2012 Pages: 47 - 64